TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Market Cap (In TWD)

1.12 Billion

Revenue (In TWD)

231.91 Million

Net Income (In TWD)

4.9 Million

Avg. Volume

9923.00

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
30.4-47.8
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006939002
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
-
Employee Count
-
Website
https://www.tfbsbio.com
Ipo Date
2023-05-16
Details
TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.